Weight-loss drug Ozempic approved for use in India: Benefits, risks, price, and all you need to know about

India’s CDSCO has approved Ozempic (semaglutide) for adults with type 2 diabetes. The once-weekly injection improves blood sugar, aids weight loss, and reduces heart risks. Side effects include nausea, pancreatitis, and kidney issues. Pricing is expected at Rs